Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTGE
426
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $40.2M | 0.06% |
2,070,490
+280,984
| +16% | +$5.37M |
|
427
Acadia Healthcare
ACHC
$2.59B
| $40.1M | 0.06% |
838,868
+767,637
| +1,078% | +$37.4M |
|
428
HF Sinclair
DINO
$17.3B
| $40M | 0.06% |
+1,111,634
| New | +$33.4M |
|
429
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.86B
| $40M | 0.06% |
293,206
+291,406
| +16,189% | +$36.5M |
|
430
Incyte
INCY
$25.9B
| $39.9M | 0.06% |
+341,732
| New | +$43.2M |
|
431
Quest Diagnostics
DGX
$27B
| $39.8M | 0.06% |
425,349
+123,127
| +41% | +$13.1M |
|
432
Plains GP Holdings
PAGP
$5.31B
| $39.7M | 0.06% |
1,815,098
+976,909
| +117% | +$23.2M |
|
433
Smith & Nephew
SNN
$12.2B
| $39.6M | 0.06% |
1,088,968
-113,793
| -9% | -$4.04M |
|
434
Brinker International
EAT
$10.6B
| $39.6M | 0.06% |
1,243,822
+1,192,372
| +2,318% | +$40.6M |
|
|
DNB
435
DELISTED
Dun & Bradstreet
DNB
| $39.6M | 0.06% |
340,357
+60,846
| +22% | +$6.76M |
|
436
Suncor Energy
SU
$80B
| $39.5M | 0.06% |
1,127,891
-60,591
| -5% | -$1.93M |
|
437
Conduent
CNDT
$250M
| $39.5M | 0.06% |
2,518,426
-700,648
| -22% | -$11.4M |
|
438
Sempra
SRE
$54.2B
| $39.4M | 0.06% |
690,324
+520,006
| +305% | +$30.1M |
|
|
ZGNX
439
DELISTED
Zogenix, Inc.
ZGNX
| $39.4M | 0.06% |
1,122,952
+1,002,208
| +830% | +$13.6M |
|
440
Donaldson
DCI
$10.8B
| $39.2M | 0.06% |
853,477
+839,293
| +5,917% | +$38.8M |
|
441
MKS Inc
MKSI
$18.9B
| $39.2M | 0.06% |
414,525
+7,473
| +2% | +$611K |
|
|
GRFS
442
Grifois
GRFS
$5.44B
| $39.1M | 0.06% |
1,786,932
+339,819
| +23% | +$7.05M |
|
443
TE Connectivity
TEL
$58.9B
| $39.1M | 0.06% |
470,412
-486,459
| -51% | -$39.1M |
|
|
SRCI
444
DELISTED
SRC Energy Inc
SRCI
| $39.1M | 0.06% |
4,040,202
+1,586,360
| +65% | +$12.5M |
|
445
Monster Beverage
MNST
$93.6B
| $39M | 0.06% |
2,824,640
+2,401,468
| +567% | +$32.4M |
|
446
Tapestry
TPR
$26B
| $38.9M | 0.06% |
966,161
+335,238
| +53% | +$14.8M |
|
447
NetApp
NTAP
$37.7B
| $38.7M | 0.06% |
883,807
-768,991
| -47% | -$31.7M |
|
448
Textron
TXT
$14.3B
| $38.6M | 0.06% |
716,797
-442,272
| -38% | -$22M |
|
449
Old Republic International
ORI
$10B
| $38.5M | 0.06% |
1,955,207
+974,839
| +99% | +$18.9M |
|
450
CALL
Comcast
CMCSA
$95.3B
| $38.5M | 0.06% |
1,000,000
+500,000
| +100% | +$19.7M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.